Lumen Bioscience develops and commercializes biologic drugs using a patented production platform that makes drug development faster, cheaper, and scalable. Biologic drugs are therapeutic proteins produced from living cells, and Lumen Bio uses its technology to manufacture these biologics more efficiently and at a lower cost, enabling broader access for patients. The company’s products are designed to treat conditions like inflammatory bowel disease and metabolic diseases, and it serves hospitals, healthcare providers, and patients. Unlike traditional biopharma methods that can be slow and expensive, Lumen Bio focuses on scaling production and reducing development time to offer more affordable biologics. Its goal is to bring safe and effective biologic therapies to a wider patient population, address neglected health issues, and improve outcomes for diseases with high unmet need.
Company Size
51-200
Company Stage
Grant
Total Funding
$174.6M
Headquarters
Seattle, Washington
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?